corisbio产品代理
corisbio产品代理
Coris BioConcept 通过开发用于 SARS-CoV-2 抗原检测的快速 ICT 检测方法，走在应对 COVID-19 的最前沿。最近，还开发并验证了血清学单一测试，用于检测和区分针对 NP 和 RBD 的抗体。
Coris BioConcept 为定制测试开发和合同制造提供服务。该公司的业务遍及欧洲、亚洲、南美洲、非洲和大洋洲的 80 多个国家。
Coris BioConcept 不断参与与比利时和欧洲研究所、实验室和公司的合作项目，以开发突破性的新解决方案。
ased in Belgium and established in 1996, Coris BioConcept is a middle-sized company (SME) specialized in developing, manufacturing and marketing rapid diagnostic kits for the detection of human respiratory, gastro-enteric and blood-borne pathogens (bacteria, viruses and parasites) and for the detection of antibiotic resistance markers (RESIST range). These tests are based on the lateral flow immunochromatography technology with colloidal gold particles or latex microspheres. These rapid tests are extensively used in microbiology laboratories worldwide.
Coris BioConcept was at the forefront to tackle COVID-19 by developing a rapid ICT assay for SARS-CoV-2 antigen detection. Recently, a serological single test has also been developed and
validated for the detection and discrimination of antibodies against NP and RBD.
Coris BioConcept provides services for custom tests development and contract manufacturing. The company is present in more than 80 countries in Europe, Asia, South America, Africa and Oceania.
Coris BioConcept is continually involved in collaborative projects with Belgian and European Research Institutes, laboratories and companies for the development of breaking new solutions.
